Safety & Transparency for the Commercial Internet

Understand why the FDA is cracking down on certain nicotine pouches and learn what to watch out for.

While generative artificial intelligence offers many capabilities and benefits for content creation, it has also opened doors to novel methods of fraud, which have already impacted the way payment service providers manage merchant risk. Learn about three key GenAI-driven risks payments professionals should expect for 2025.

LegitScript is the industry-leading certification provider for Addiction Treatment, Healthcare, and CBD certification.

In this article, we’ll explore the role of MCCs in the larger payments ecosystem, and provide a comprehensive list of high-risk MCCs.

LegitScript joins the global effort to spread awareness surrounding the detection and prevention of fraud.

Counterfeits, unapproved brands, problematic ads, shady affiliates, and scams are just a few of the problems erupting from the GLP-1 market. In this webinar, we’ll explore how illicit GLP-1 sellers are infiltrating merchant portfolios and e-commerce marketplaces, and share how to stop this risk. Register now.

To celebrate International Fraud Awareness Week (Nov. 17-23, 2024), LegitScript is happy to present a special webinar on best practices to detect transaction laundering. Register now.

LegitScript’s rankings of the top high-risk trends in payments and e-commerce are based on its work monitoring merchants and sellers.

In this updated guide for 2025 and beyond, LegitScript shares new high-risk trends that companies engaged in online transactions should be aware of to avoid expensive assessments levied by card networks for violations. You will also see case studies of problematic merchants and find additional resources to help answer common questions about these trends and how to navigate them.

Illicit counterfeit sales are a multi-trillion-dollar scourge on the global marketplace — and hiding in plain sight.

The Treasury released an exposure draft of the bill — let’s explore the reforms and consumer protections they plan to implement.

Explore how our solutions help extend internal teams’ bandwidth by flagging merchants in your downstream merchant portfolios.

The booming weight loss drug market presents opportunities for manufacturers and retailers but also risks exploitation, including counterfeit and dangerous products, reminiscent of past health trends. A surging market can create opportunities for retailers but also put them and their consumers at risk of illicit, counterfeit, and dangerous products. Here’s what you need to know.

The payments risk and compliance space is dynamic — it must constantly adapt to advancing technologies, changing regulations, criminal innovation, and new products. In this webinar hosted by the Association of Payment Professionals, LegitScript experts share emerging high-risk trends in payment processing based on their recent work monitoring millions of merchants.

We delve into the defining characteristics of the parties responsible for the various types of fraud and/or merchant risk.

You have your LegitScript Certification, and now you want to make the most of it. Where do you start? In this free, one-hour webinar, experts from Dreamscape Marketing answer common questions and share best practices for optimizing your digital marketing strategies to drive engagement, reach patients, and make sure your brand stands out above the rest.

A collaboration between LegitScript and EMS sets a new standard for ensuring that online pharmacies, telemedicine providers, and other healthcare businesses comply with applicable laws and regulations while providing secure, compliant payment transactions for their customers.

This September, LegitScript is joining with our partners and community in celebration of National Recovery Month.

Ensure your CBD products are compliant and demonstrate trustworthiness to consumers — with LegitScript.

Counterfeit or otherwise unsafe or ineffective drugs pose innumerable risks that compound when they’re sold by illicit online pharmacies.